 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Changing Pattern of Community-Acquired Skin and Soft-Tissue Infection with Antibiotic-Resistant Staphylococcus aureus
7 March 2006 | Volume 144 Issue 5 | Page I-11
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections." It is in the 7 March 2006 issue of Annals of Internal Medicine (volume 144, pages 309-317). The authors are M.D. King, B.J. Humphrey, Y.F. Wang, E.V. Kourbatova, S.M. Ray, and H.M. Blumberg.
What is the problem and what is known about it so far?
Staphylococcus aureus (S. aureus) is a common type of bacteria that often lives on the surface of the skin of healthy people without causing infection. Sometimes these bacteria penetrate the skin and cause infection of the skin or the tissues underneath (called skin and soft-tissue infections). As a result of overusing antibiotics, certain strains of S. aureus have developed resistance to important antibiotics, such as methicillin, that have been used to treat these types of infections. In the past, doctors have found antibiotic-resistant or methicillin-resistant S. aureus (MRSA) mostly in patients who became infected while they were in a hospital or another health care facility, as opposed to methicillin-sensitive S. aureus (MSSA), which was mostly found in infections that had started outside the hospital setting. Treatment of MRSA requires special types of antibiotics, some of which must be given through veins when initially treating serious or life-threatening infections. Recently, doctors have been finding MRSA with increasing frequency outside the hospital in the general community (community-acquired MRSA). Initially this seemed to occur most often in particular groups of people, such as inmates of correctional facilities, homosexual men, and members of sports teams. Doctors need to know how the pattern of infection with MRSA is changing because treatment practices may need to be changed.
Why did the researchers do this particular study?
To determine the proportion and clinical characteristics of skin and soft-tissue infections in the general community that were caused by MRSA and whether the types of people being infected by MRSA were changing.
Who was studied?
384 patients cared for at Grady Memorial Hospital in Atlanta, Georgia, and its outpatient clinics who had acquired S. aureus skin or soft-tissue infections outside the hospital.
How was the study done?
The authors collected information from the Grady Health System microbiology laboratory and from medical records on patients with skin and soft-tissue infections due to S. aureus. They then separated the results according to whether the bacteria were MRSA or MSSA and did further analysis on the specific genetic types of MRSA and whether they were sensitive or resistant to different antibiotics.
What did the researchers find?
A total of 72% of all the S. aureus infections found in these community-acquired infections were due to MRSA. Personal factors that were more likely to be associated with MRSA infection included being black, being female, and having been hospitalized within the past year.
What were the limitations of the study?
The findings may not be characteristic of communities other than Atlanta, Georgia.
What are the implications of the study?
Methicillin-resistant S. aureus is becoming more common as a cause of skin and soft-tissue infection in the community setting, and this will require adjustment in antibiotic coverage for serious MRSA infections.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  A. El-Sharif and H. M. Ashour Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Colonization and Infection in Intravenous and Inhalational Opiate Drug Abusers Experimental Biology and Medicine, July 1, 2008; 233(7): 874 - 880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nathwani, M. Morgan, R. G. Masterton, M. Dryden, B. D. Cookson, G. French, D. Lewis, and on behalf of the British Society for Antimicrobial Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community J. Antimicrob. Chemother., May 1, 2008; 61(5): 976 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rathore Mother-to-child Transmission of MRSA Unlikely Cause of Neonatal Infection AAP Grand Rounds, May 1, 2008; 19(5): 58 - 58. [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Chung, H.-S. Jeon, H. Sung, M.-N. Kim, and S.-J. Hong Epidemiological Characteristics of Methicillin-Resistant Staphylococcus aureus Isolates from Children with Eczematous Atopic Dermatitis Lesions J. Clin. Microbiol., March 1, 2008; 46(3): 991 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Sader, T. R. Fritsche, and R. N. Jones Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1153 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Olsen, K. M. Burns, L. Chen, B. N. Kreiswirth, and J. M. Musser Severe Necrotizing Fasciitis in a Human Immunodeficiency Virus-Positive Patient Caused by Methicillin-Resistant Staphylococcus aureus J. Clin. Microbiol., March 1, 2008; 46(3): 1144 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Maresso and O. Schneewind Sortase as a Target of Anti-Infective Therapy Pharmacol. Rev., March 1, 2008; 60(1): 128 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Diep, H. F. Chambers, C. J. Graber, J. D. Szumowski, L. G. Miller, L. L. Han, J. H. Chen, F. Lin, J. Lin, T. H. Phan, et al. Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men Ann Intern Med, February 19, 2008; 148(4): 249 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Herman, V. R. Kee, K. G. Moores, and M. B. Ross Etiology and treatment of community-associated methicillin-resistant Staphylococcus aureus Am. J. Health Syst. Pharm., February 1, 2008; 65(3): 219 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Campbell, H. S. Deshmukh, C. L. Nelson, I.-G. Bae, M. E. Stryjewski, J. J. Federspiel, G. T. Tonthat, T. H. Rude, S. L. Barriere, R. Corey, et al. Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections J. Clin. Microbiol., February 1, 2008; 46(2): 678 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Kennedy, M. Otto, K. R. Braughton, A. R. Whitney, L. Chen, B. Mathema, J. R. Mediavilla, K. A. Byrne, L. D. Parkins, F. C. Tenover, et al. From the Cover: Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification PNAS, January 29, 2008; 105(4): 1327 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Moellering Jr A 39-Year-Old Man With a Skin Infection JAMA, January 2, 2008; 299(1): 79 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Witte, B. Strommenger, C. Cuny, D. Heuck, and U. Nuebel Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006 J. Antimicrob. Chemother., December 1, 2007; 60(6): 1258 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gupta, A. MacIntyre, G. Vanasse, and L.-M. Dembry Trends in Prescribing -Lactam Antibiotics for Treatment of Community-Associated Methicillin-Resistant Staphylococcus aureus Infections J. Clin. Microbiol., December 1, 2007; 45(12): 3930 - 3934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Korownyk and G. M. Allan Evidence-based approach to abscess management Can Fam Physician, October 1, 2007; 53(10): 1680 - 1684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Ellis, M. E. Griffith, D. P. Dooley, J. C. McLean, J. H. Jorgensen, J. E. Patterson, K. A. Davis, J. S. Hawley, J. A. Regules, R. G. Rivard, et al. Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3591 - 3598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Ruhe and A. Menon Tetracyclines as an Oral Treatment Option for Patients with Community Onset Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3298 - 3303. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Jones, A. M. Nilius, B. K. Akinlade, L. M. Deshpande, and G. F. Notario Molecular Characterization of Staphylococcus aureus Isolates from a 2005 Clinical Trial of Uncomplicated Skin and Skin Structure Infections Antimicrob. Agents Chemother., September 1, 2007; 51(9): 3381 - 3384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Harrington and M. T. Munekata Update in General Internal Medicine Ann Intern Med, July 17, 2007; 147(2): 104 - 116. [Full Text] [PDF]
|
|
|
|
|
|
K. Popovich, B. Hota, T. Rice, A. Aroutcheva, and R. A. Weinstein Phenotypic Prediction Rule for Community-Associated Methicillin-Resistant Staphylococcus aureus J. Clin. Microbiol., July 1, 2007; 45(7): 2293 - 2295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-H. Kwon and C.-D. Lu Polyamine Effects on Antibiotic Susceptibility in Bacteria Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2070 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hota, C. Ellenbogen, M. K. Hayden, A. Aroutcheva, T. W. Rice, and R. A. Weinstein Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections at a Public Hospital: Do Public Housing and Incarceration Amplify Transmission? Arch Intern Med, May 28, 2007; 167(10): 1026 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Szumowski, D. E. Cohen, F. Kanaya, and K. H. Mayer Treatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory Clinic Antimicrob. Agents Chemother., February 1, 2007; 51(2): 423 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hawkes, M. Barton, J. Conly, L. Nicolle, C. Barry, and E. L. Ford-Jones Community-associated MRSA: Superbug at our doorstep Can. Med. Assoc. J., January 2, 2007; 176(1): 54 - 56. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Phillips, C. MacDougall, and D. A Holdford Analysis of Empiric Antimicrobial Strategies for Cellulitis in the Era of Methicillin-Resistant Staphylococcus aureus Ann. Pharmacother., January 1, 2007; 41(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. McDonald, A. Dougall, D. Holt, F. Huygens, F. Oppedisano, P. M. Giffard, J. Inman-Bamber, A. J. Stephens, R. Towers, J. R. Carapetis, et al. Use of a Single-Nucleotide Polymorphism Genotyping System To Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal Communities. J. Clin. Microbiol., October 1, 2006; 44(10): 3720 - 3727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Grayson The Treatment Triangle for Staphylococcal Infections. N. Engl. J. Med., August 17, 2006; 355(7): 724 - 727. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Johnson Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection. Ann Intern Med, August 1, 2006; 145(3): 232 - 232. [Full Text] [PDF]
|
|
|
|
|
|
K. N.F. de Almeida and L. M. Bush Treatment of community-acquired methicillin-resistant Staphylococcus aureus infection. Ann Intern Med, August 1, 2006; 145(3): 231 - 232. [Full Text] [PDF]
|
|
|
|
|
|
M. Gilbert, J. MacDonald, D. Gregson, J. Siushansian, K. Zhang, S. Elsayed, K. Laupland, T. Louie, K. Hope, M. Mulvey, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration Can. Med. Assoc. J., July 18, 2006; 175(2): 149 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Robbins MRSA Outnumbers MSSA for Common Skin Infections Acquired in the Community AAP Grand Rounds, July 1, 2006; 16(1): 77 - 78. [Full Text] [PDF]
|
|
|
|
|
|
K. E Sabol, K. L Echevarria, and J. S Lewis II Community-Associated Methicillin-Resistant Staphylococcus aureus: New Bug, Old Drugs Ann. Pharmacother., June 1, 2006; 40(6): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Staph Infections: Think Beyond "Keflex" Journal Watch Emergency Medicine, April 25, 2006; 2006(425): 10 - 10. [Full Text]
|
|
|
|
 |
|
 Community-Acquired MRSA Skin Infections: Not Uncommon Journal Watch Dermatology, April 11, 2006; 2006(411): 1 - 1. [Full Text]
|
|
|
|
 |
|
 MRSA in the Community Journal Watch Infectious Diseases, April 7, 2006; 2006(407): 2 - 2. [Full Text]
|
|
|
|
 |
|
 Community-Acquired MRSA Skin Infections: Not Uncommon Journal Watch (General), March 31, 2006; 2006(331): 7 - 7. [Full Text]
|
|
|
|
|
|
R. C. Moellering Jr. The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. Ann Intern Med, March 7, 2006; 144(5): 368 - 370. [Full Text] [PDF]
|
|
Read all Rapid Responses
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
